Celiac Disease Registry

Overview

About this study

The purpose of this study is to develop a resource (bank) of biospecimens (blood, tissue, stool) and data collected from individuals with known or suspected gluten enteropathy, including celiac disease (CD) and dermatitis herpetiformis (DH).  Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, Whipple’s disease, and other miscellaneous inflammatory disorders of the small intestine. This resource will be invaluable in answering the important questions outlined above and other future unanswered questions.   

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Age greater than 3 years
  • All subjects will be included even those with a suspected diagnosis of celiac disease and/or dermatitis herpetiformis.
  • Patients with
    • Collagenous sprue 
    • Idiopathic sprue 
    • Lymphocytic enterocolitis 
    • Idiopathic enteropathies 
    • Collagenous gastritis 
    • Whipple’s disease 
    • Other miscellaneous inflammatory disorders of the small intestine

Exclusion Criteria:

  • Vulnerable population

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joseph Murray, M.D.

Open for enrollment

Contact information:

Carol Van Dyke CCRP

(507)266-7842

VanDyke.Carol@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available